Q-omics provides the consensus-scored RNA5SP302 profile across patient tissues and cancer cell-line models. RNA5SP302 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in CHOL. Additionally, RNA5SP302 RNA expression shows 6,320 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight CHOL, and STAD as cancer lineages where RNA5SP302 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNA5SP302 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNA5SP302 survival associations across molecular data types. RNA5SP302 RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNA5SP302 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	10	CHOL (108)	view →

This table ranks reproducible RNA5SP302 RNA expression–survival associations across cancer types. High RNA5SP302 expression shows unfavorable associations in CHOL, THCA, STAD, LUAD and KIRC, but favorable associations in OV. The CHOL Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify CHOL as the clearest survival context for RNA5SP302 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.728	<.001	108	view →
THCA	OS	Tertile	II,III,IV	0.579	0.988	<.001	102	view →
OV	DFS	Tertile	III,IV	0.721	0.517	.006	54	view →
STAD	OS	Tertile	II,III,IV	0.494	0.740	.015	27	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	18	view →
KIRC	OS	Tertile	All	0.501	0.663	.017	12	view →

Pink = unfavorable, green = favorable. all 10 lineages →

RNA5SP302-CHOL (OS)

Kaplan–Meier survival curve for RNA5SP302 RNA expression in CHOL: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNA5SP302 in patient tissues and cancer cell lines. In patient samples, RNA5SP302 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,320	STAD (5952)	view →
RNA	5,157	COAD (1535)	view →